Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Eric Renard MD, PhD, FRCPEdin

Prof Eric Renard MD, PhD, FRCPEdin

Head of the Department of Endocrinology, Diabetes and Nutrition and of the INSERM 1411 Clinical Investigation Centre, Montpellier University Hospital, University of Montpellier, Montpellier, France

Eric Renard is Chair and Professor of Endocrinology, Diabetes and Metabolism at the University of Montpellier, France, since 1999. He also leads the Department of Endocrinology, Diabetes and Nutrition at Montpellier University Hospital and is Head of the INSERM Clinical Research Centre at Montpellier University Hospital. Eric Renard is also co-leader of a research team on “Innovative therapeutics for diabetes: understanding and correction of insulin secretion dysfunction and loss” at the Institute of Functional Genomics affiliated to CNRS, INSERM and the University of Montpellier.

Professor Renard received his medical degree (Montpellier Medical School, 1987), completed a Research Fellowship at Joslin Diabetes Center (Harvard Medical School, Boston, USA, 1992), and received his PhD in Biochemistry & Molecular Biology (University of Montpellier, 1995).

Professor Renard devoted his research work to the development of innovative technologies aiming at a physiological delivery of insulin for the therapy of diabetes mellitus, including wearable and implantable insulin pumps, intra-peritoneal insulin delivery, continuous glucose monitoring and closed-loop insulin delivery systems. His research activity has been supported by grants from the Juvenile Diabetes Research Fundation, the European Commission, the French Ministry of Health, and the American National Institute of Health. Eric Renard authored more than 280 peer-reviewed papers.

Disclosures

Consultant: Abbott, Air Liquide SI, Asten, Astra-Zeneca, Bastide Médical, Boehringer-Ingelheim, Dexcom Inc., Dinno-Santé, Eli-Lilly, Hillo, Insulet Inc., LifeScan, Medtronic, Medirio, Nestlé Home Care, Novo-Nordisk, Orkyn, Roche, Sanofi-Aventis, VitalAire.

Soutiens pour la Recherche:  Dexcom Inc., Insulet Inc., Roche, Tandem.

Recent Contributions to PracticeUpdate:

  1. Diabetes Incidence After Infection With COVID-19